Valion Bio Inc share price logo

Valion Bio Inc

NASDAQ: VBIO

Small Cap

$0.56

-0.01

(-1.24%)

as on

Valion Bio Inc Stock Performance

as on June 16, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.54
    $0.59
    downward going graph

    3.57%

    Downside

    5.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Valion Bio Inc share price movements today

Previous Close
$0.57
Open
$0.55
Volume
424.3K
Day's Low - High
$0.54 - $0.59

Valion Bio Inc Historical Returns

1 Month Return
-36.48 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Valion Bio Inc Stock Fundamentals & Key Indicators

Check Valion Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-182.22%

Valion Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Valion Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$1.8MNANA0.00%NA
BUY$37.8B71%70.8912.55%NA
BUY$112.9B140.26%26.3935.51%NA
BUY$64.2B17.46%14.9529.65%0.59%

Indian Investors' Interest in Valion Bio Inc Stock

Search interest for Valion Bio Inc Stock has increased by 553% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:553% versus previous 30 day period

Valion Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
0
0
0
0
Gross Profit
0
0
0
0
-
-
Operating Income
-1
-1
-1
0
-1
-1
EBITDA
-
-
-
0
-
-1
Interest Expense
-
-
-
0
-
0
Depreciation
0
0
0
-
0
0
Income Before Tax
-1
-1
-1
0
-1
-1
Income Tax Expense
-
-
-
-
-
-
Net Income
-1
-1
-1
0
-2
-1
Net Profit Margin
-820.56%
0.00%
-2245.35%
-81.33%
943.38%
-200.32%

Valion Bio Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
-
-
1
1
-
-
Gross Profit
0
0
-
-
0
0
0
-
Operating Income
-
-
-
-
-10
-8
-4
-7
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
0
Depreciation
-
-
-
-
0
0
0
0
Income Before Tax
-
-
-
-
-10
-8
-4
-7
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-4
-13
-4
0
-10
-8
-5
-8
Net Profit Margin
-4207.22%
-5080.21%
0.00%
0.00%
-548.70%
-701.02%
0.00%
0.00%

Valion Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
0
-1
-1
-1
4
-2
-1
Operating Cash Flow
0
0
0
-1
0
-1
0
-2
0
Investing Cash Flow
-
-
-
-
-
-
0
-
-
Financing Cash Flow
-
-
0
1
0
2
0
11
0
Change in Cash
0
0
0
0
-1
0
0
9
0

Valion Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-4
-4
0
-8
-10
-8
-5
-8
Operating Cash Flow
-1
-2
-3
-1
-
-8
-8
-5
-6
Investing Cash Flow
-
-
0
-
-
-
-
-
-
Financing Cash Flow
2
2
8
0
-
0
8
4
18
Change in Cash
1
0
-3
-1
-
-9
0
-1
10

Global Institutional Holdings in Valion Bio Inc

Funds
Holdings
XTX Topco Ltd
0.33%
Susquehanna International Group, LLP
0%
Citigroup Inc
0%
Bank of America Corp
0%
HRT FINANCIAL LLC
1.33%

Insights on Valion Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Valion Bio, Inc. Common Stock has experienced a drawdown of -99.7%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 78.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 17.7% return, outperforming this stock by 102.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VBIO stock has moved down by -24.4%

About Valion Bio Inc

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
OrganisationValion Bio Inc
Headquarters1305 E. Houston Street, San Antonio, TX, United States, 78205
IndustryBiotechnology
CEOMr. Michael Kevin Handley
E-voting on sharesClick here to vote

Key Management of Valion Bio Inc

Name

Title

Mr. Michael Kevin Handley

CEO & Director

Ms. Lisa G. Wolf

CFO and Principal Financial & Principal Accounting Officer

Ms. Melinda Lackey

General Counsel & Senior Vice President of Legal Affairs

FAQs

What is Valion Bio Inc share price today?

Valion Bio Inc share price today is $0.56 as on at the close of the market. Valion Bio Inc share today touched a day high of $0.59 and a low of $0.54.

What is the 52 week high and 52 week low for Valion Bio Inc share?

Valion Bio Inc share touched a 52 week high of $0 on and a 52 week low of $0 on . Valion Bio Inc stock price today i.e. is closed at $0.56,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Valion Bio Inc's market capitalisation today?

Valion Bio Inc market capitalisation is $0.00T as on .

How to invest in Valion Bio Inc Stock (VBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Valion Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Valion Bio Inc Shares that will get you 2.6786 shares as per Valion Bio Inc share price of $0.56 per share as on June 16, 2026 at 8:45 am IST.

What is the minimum amount required to buy Valion Bio Inc Stock (VBIO) from India?

Indian investors can start investing in Valion Bio Inc (VBIO) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Valion Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Valion Bio Inc share’s latest price of $0.56 as on June 16, 2026 at 8:45 am IST, you will get 17.8571 shares of Valion Bio Inc. Learn more about fractional shares .